New treatments for mitochondrial diseases: update on recent and current clinical trials

17 September 2022
PLENARY MITO
• 17-AM-Plenary • 08:30 > 10:00 • New treatments for mitochondrial diseases: update on recent and current clinical trials • Athena Auditorium

08:30 • MITOS7L1 • Clinical trials landscape in primary mitochondrial diseases in the USA: looking into the future > A. Amel KARAA 08:45 • MITOS7L2 • Sonlicromanol in primary mitochondrial disease MELAS spectrum disorders > J. Jan SMEITINK 09:00 • MITOS7L3 • Mitochondrial disease clinical trials: experience gained at the London highly specialised service for rare mitochondrial disorders > R. Robert PITCEATHLY 09:15 • MITOS7L4 • Elamipretide treatment and Barth syndrome: combined data from a phase 2/3 clinical trial and a natural history comparison study > H. Hilary VERNON 09:30 • MITOS7L5 • General discussion between the panel and the audience
Copyright © key4events - All rights reserved